Lead EvaluAtion for Defibrillation and Reliability (LEADR)
Recruiting
18 years - 99 years
All
500 participants needed
1 Location
Brief description of study
The research study is being conducted to assess the safety and efficacy of Medtronic’s Next Generation ICD lead.
Duration 18 to 36 months.
Detailed description of study
The research study is being conducted to assess the safety and efficacy of Medtronic’s Next Generation ICD lead.
Duration 18 to 36 months.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Heart, Cardiac, Defibrillation
-
Age: 18 years - 99 years
-
Gender: All
Adults diagnosed with heart disease whose doctor recommends implant of an ICD or CRT-D device.
Updated on
04 Aug 2024.
Study ID: 850232